Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple-Negative Breast Cancer
Interventions: DRUG: VEGFR and nab-paclitaxel, with maintenance of VEGFR and capecitabine|DRUG: nab-paclitaxel, with maintenance of capecitabine|DRUG: Eribulin Mesylate/Vinorelbine/Capecitabine/Carboplatin/UTD1|DRUG: VEGFR and TPC
Sponsor: Fudan University